Related Experiment Videos
The antinarcoleptic drug modafinil increases glutamate release in thalamic areas and hippocampus
L Ferraro1, T Antonelli, W T O'Connor
1Department of Experimental and Clinical Medicine, University of Ferrara, Italy.
Abstract:
The antinarcoleptic drug modafinil [(diphenyl-methyl)-sulfinyl-2-acetamide; Modiodal] dose-dependently inhibits the activity of GABA neurons in the cerebral cortex and in the nucleus accumbens, as well as in sleep-related brain areas such as the medial preoptic area and the posterior hypothalamus. This study examined the effects of modafinil (30-300 mg/kg, i.p.) on dialysate glutamate and GABA levels in the ventromedial (VMT) and ventrolateral (VLT) thalamus and hippocampal formation (Hip) of the awake rat. The results show a maximal increase in glutamate release in these brain regions at the 100 mg/kg dose, associated with a lack of effect on GABA release. Thus modafinil may increase excitatory glutamatergic transmission in these regions, altering the balance between glutamate and GABA transmission.
Insights
Modafinil, a narcolepsy drug, increases glutamate release in specific brain areas without affecting GABA levels. This suggests modafinil enhances excitatory neurotransmission, potentially altering brain activity balance.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Modafinil is an antinarcoleptic drug known to inhibit GABA neurons in various brain regions.
- The precise mechanisms by which modafinil affects neurotransmitter release, particularly glutamate and GABA, require further elucidation.
Purpose of the Study:
- To investigate the effects of modafinil on dialysate glutamate and GABA levels in specific thalamic and hippocampal regions of awake rats.
- To determine the dose-dependent relationship between modafinil administration and changes in excitatory and inhibitory neurotransmitter release.
Main Methods:
- Administration of modafinil (30-300 mg/kg, intraperitoneally) to awake rats.
- Measurement of dialysate glutamate and GABA levels in the ventromedial thalamus (VMT), ventrolateral thalamus (VLT), and hippocampal formation (Hip) using microdialysis.
Main Results:
- Modafinil caused a dose-dependent increase in glutamate release, with maximal effect observed at 100 mg/kg.
- No significant effect of modafinil on GABA release was detected in the studied brain regions.
- The findings indicate a potential enhancement of glutamatergic transmission by modafinil.
Conclusions:
- Modafinil may preferentially increase excitatory glutamatergic transmission in the VMT, VLT, and Hip.
- This modulation of neurotransmitter balance could contribute to modafinil's wakefulness-promoting effects.
- Further research is warranted to understand the implications of altered glutamate-GABA balance in modafinil's therapeutic actions.